Life Science Reagents Market Size, Share, Growth, and Industry Analysis, By Type (Cell and tissue culture reagents, Clinical chemistry reagents, Immunoassay reagents, Molecular diagnostic reagents, Other), By Application (Scientific research, Pharmaceuticals, Other), Regional Insights and Forecast to 2035

Life Science Reagents Market Overview

Life Science Reagents Market size is estimated at USD 58196.8 million in 2026 and is expected to reach USD 157151.19 million by 2035 at a 11.67% CAGR.

The Life Science Reagents Market is expanding rapidly due to increasing laboratory testing volumes, rising biotechnology research activities, and growing demand for advanced diagnostic solutions across pharmaceutical, clinical, and academic sectors. Life science reagents are essential components used in molecular biology, cell biology, immunology, clinical diagnostics, and genomic sequencing applications. More than 68% of biotechnology laboratories globally rely on molecular diagnostic reagents for routine analysis and drug discovery workflows. Approximately 57% of pharmaceutical manufacturers increased procurement of analytical and assay reagents due to rising biologics and vaccine production activities. Clinical laboratories account for nearly 46% of total reagent utilization worldwide, driven by increasing infectious disease testing and personalized medicine adoption. Automation in laboratories has increased reagent consumption efficiency by over 38%, while high-throughput screening platforms have expanded by approximately 41% in research institutes. The Life Science Reagents Market Report highlights strong demand from genomics, proteomics, and precision medicine sectors, contributing significantly to Life Science Reagents Market Growth and Life Science Reagents Market Opportunities.

The United States dominates the Life Science Reagents Market due to advanced healthcare infrastructure, strong biotechnology investments, and widespread pharmaceutical research activities. More than 72% of clinical laboratories in the country utilize molecular diagnostic reagents for infectious disease detection and cancer screening applications. Approximately 64% of biotechnology firms in the U.S. increased reagent procurement for genomic sequencing and cell culture operations. Over 58% of academic research institutions expanded immunoassay reagent usage for biomarker studies and drug development projects. The country also records high adoption of automated laboratory systems, with nearly 49% of laboratories integrating robotic reagent handling systems. Government-supported biomedical research initiatives increased laboratory reagent demand by around 44%, while precision medicine programs boosted molecular biology reagent usage by approximately 52% across hospitals and research facilities.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Molecular diagnostics adoption increased by 58%, genomic sequencing procedures rose by 49%, and biologics research activities expanded by 46%, significantly increasing demand for high-purity laboratory reagents across pharmaceutical, biotechnology, and clinical diagnostic industries worldwide.
• Major Market Restraint: Around 41% of laboratories reported supply chain disruptions, while 37% experienced raw material shortages and 34% faced reagent storage limitations, impacting procurement efficiency and laboratory workflow continuity in several developing regions.
• Emerging Trends: Automated reagent dispensing systems adoption increased by 44%, AI-integrated laboratory testing expanded by 39%, and personalized medicine applications grew by 53%, creating strong momentum for advanced life science reagent technologies and precision diagnostics.
• Regional Leadership: North America accounts for nearly 39% laboratory reagent utilization, while Asia-Pacific research activities increased by 47% and European clinical diagnostic reagent demand expanded by 36% due to biotechnology infrastructure advancements.
• Competitive Landscape: Approximately 48% of leading manufacturers focused on molecular diagnostic reagent expansion, 43% invested in automation-compatible formulations, and 35% strengthened distribution partnerships to improve laboratory reagent accessibility and production scalability globally.
• Market Segmentation: Molecular diagnostic reagents represent nearly 34% of product demand, immunoassay reagents account for 27%, clinical chemistry reagents contribute 21%, while cell culture reagents comprise approximately 18% of laboratory applications globally.
• Recent Development: Around 42% of biotechnology companies launched advanced PCR reagent kits, 38% expanded genomic reagent portfolios, and 33% introduced automation-ready laboratory reagents to support high-throughput research and clinical diagnostics applications.

Life Science Reagents Market Latest Trends

The Life Science Reagents Market Trends indicate rapid advancements in molecular diagnostics, personalized medicine, and laboratory automation technologies. Approximately 61% of research laboratories increased the use of next-generation sequencing reagents due to rising genomic analysis activities. Automated reagent preparation systems witnessed nearly 45% adoption growth across biotechnology and pharmaceutical laboratories to improve testing accuracy and workflow efficiency. More than 52% of hospitals integrated molecular diagnostic reagent systems for infectious disease monitoring and cancer biomarker detection. Demand for cell and tissue culture reagents expanded by approximately 48% because of increasing regenerative medicine and stem cell therapy research. Immunoassay reagent utilization increased by 43% in clinical laboratories due to rising chronic disease screening programs. Proteomics research activities also contributed significantly, with over 37% growth in protein analysis reagent demand globally. Asia-Pacific laboratories reported nearly 51% expansion in biotechnology testing capabilities, increasing reagent procurement across research institutions. Sustainable and eco-friendly reagent packaging initiatives rose by 29% among major manufacturers aiming to reduce laboratory waste. The Life Science Reagents Market Analysis further highlights increasing investment in AI-enabled laboratory platforms and high-throughput diagnostic systems to support precision medicine applications and advanced biomedical research activities.

Life Science Reagents Market Dynamics

DRIVER

"Rising demand for molecular diagnostics and genomic research"

The increasing prevalence of chronic diseases, infectious disorders, and genetic abnormalities has significantly accelerated demand for molecular diagnostic and genomic research reagents. Approximately 59% of clinical laboratories expanded PCR-based testing capabilities for infectious disease analysis and cancer biomarker identification. Genomic sequencing procedures increased by nearly 54% across research institutes and pharmaceutical companies, driving strong consumption of nucleic acid extraction reagents, amplification kits, and sequencing chemicals. Biotechnology firms reported around 47% growth in reagent procurement for personalized medicine applications and targeted therapy development. More than 42% of hospitals globally adopted molecular diagnostics for early disease detection and precision treatment planning. In addition, regenerative medicine research expanded by approximately 39%, increasing demand for specialized cell culture and protein analysis reagents. Academic research institutions also increased funding allocation toward life science research activities, with laboratory testing volumes rising by nearly 36%. Automation technologies integrated into laboratory systems improved reagent handling efficiency by around 31%, enabling higher throughput and reduced testing errors. The Life Science Reagents Market Outlook remains highly positive due to ongoing innovation in molecular biology, genomics, and clinical diagnostics infrastructure worldwide.

RESTRAINTS

"Supply chain disruptions and reagent storage limitations"

The Life Science Reagents Market faces significant challenges associated with supply chain instability, storage requirements, and raw material availability. Approximately 44% of laboratories reported delays in reagent procurement due to transportation disruptions and international trade restrictions. Temperature-sensitive reagents require specialized cold chain logistics, and nearly 38% of healthcare facilities experienced storage inefficiencies affecting reagent stability and shelf life. Shortages of high-purity chemicals and biological raw materials impacted around 35% of manufacturers involved in molecular diagnostic reagent production. In developing regions, approximately 41% of laboratories lack advanced storage infrastructure required for maintaining reagent quality under controlled conditions. Regulatory compliance standards for diagnostic and clinical-grade reagents also increased operational complexities for nearly 33% of small-scale manufacturers. Frequent fluctuations in raw material supply caused production scheduling challenges across biotechnology facilities, affecting laboratory workflow continuity. Moreover, around 29% of research institutes reported budget constraints limiting procurement of advanced high-sensitivity reagents. Dependence on imported laboratory chemicals further intensified procurement difficulties in several emerging economies. These factors continue to restrain widespread accessibility and operational efficiency within the Life Science Reagents Industry Analysis despite rising global laboratory testing demand.

OPPORTUNITY

"Expansion of personalized medicine and precision diagnostics"

The rapid growth of personalized medicine and precision diagnostics creates substantial opportunities for the Life Science Reagents Market. Approximately 56% of oncology treatment centers increased biomarker testing activities to support targeted therapies and individualized treatment plans. Genomic medicine programs expanded by nearly 49% across hospitals and biotechnology firms, significantly increasing demand for sequencing reagents and molecular assay kits. Companion diagnostics adoption rose by approximately 44%, supporting pharmaceutical development and patient-specific therapeutic solutions. Artificial intelligence integration in laboratory diagnostics improved data interpretation accuracy by around 36%, encouraging advanced reagent utilization for automated testing systems. More than 41% of pharmaceutical manufacturers increased investment in biologics and cell-based therapies, boosting demand for cell culture reagents and protein analysis kits. Emerging economies also reported nearly 46% expansion in biotechnology infrastructure and laboratory modernization projects, creating favorable opportunities for reagent suppliers. Research collaboration initiatives between academic institutions and pharmaceutical companies increased by approximately 32%, accelerating innovation in biomarker discovery and genomic applications. Furthermore, growing awareness regarding preventive healthcare and early disease detection increased molecular testing volumes globally. These factors are expected to support long-term Life Science Reagents Market Opportunities and strengthen demand for specialized laboratory consumables and analytical solutions.

CHALLENGE

"High operational complexity and regulatory compliance requirements"

The Life Science Reagents Market faces critical challenges related to operational complexity, quality assurance, and stringent regulatory standards. Approximately 43% of reagent manufacturers encounter compliance difficulties associated with clinical validation and laboratory certification procedures. Regulatory approvals for diagnostic reagents require extensive testing protocols, increasing operational timelines for nearly 37% of biotechnology companies. Maintaining reagent purity, consistency, and contamination control also remains a major challenge for around 34% of production facilities. Laboratories using highly specialized reagents require skilled personnel for handling and interpretation, while approximately 31% of research institutes reported workforce shortages in molecular diagnostics and genomic testing operations. Cross-border trade regulations and varying international quality standards further complicate product distribution and manufacturing processes. Around 28% of small and medium-sized suppliers experienced difficulties adapting to changing laboratory compliance frameworks. Additionally, rapid technological advancements require continuous product innovation and manufacturing upgrades, increasing operational pressure across the industry. Data security concerns associated with digital laboratory platforms and automated testing systems also emerged as a growing challenge for biotechnology organizations implementing AI-based diagnostics and cloud-connected laboratory infrastructure.

Life Science Reagents Market Segmentation

The Life Science Reagents Market segmentation is categorized by type and application, reflecting increasing laboratory demand across biotechnology, pharmaceutical, and clinical diagnostics sectors. Molecular diagnostic reagents account for a significant portion of laboratory testing activities due to growing genomic sequencing adoption. Immunoassay reagents are widely utilized in disease detection and biomarker analysis, while clinical chemistry reagents support routine hospital diagnostics. Cell and tissue culture reagents are increasingly used in regenerative medicine and biologics development. Applications include pharmaceutical research, biotechnology laboratories, hospitals, academic institutions, and diagnostic centers. Rising laboratory automation and precision medicine adoption continue to influence segmentation growth patterns globally.

Download FREE Sample to learn more about this report.

BY TYPE

Cell and tissue culture reagents: Cell and tissue culture reagents are witnessing strong demand due to increasing stem cell research, regenerative medicine development, and biologics manufacturing activities. Approximately 53% of biotechnology laboratories expanded cell culture operations for vaccine production and monoclonal antibody research. Academic research institutions reported nearly 46% growth in tissue engineering studies utilizing specialized growth media and serum supplements. Pharmaceutical companies increased adoption of contamination-free culture reagents by around 39% to improve biologics production quality and laboratory efficiency. Three-dimensional cell culture technologies expanded by approximately 34%, increasing demand for extracellular matrix reagents and advanced tissue scaffolding materials. More than 42% of regenerative medicine projects rely heavily on cell culture reagents for therapeutic development and disease modeling applications. Automated bioprocessing systems improved reagent utilization efficiency by nearly 28% across manufacturing facilities. Increased investment in personalized therapies and cell-based drug discovery programs also accelerated consumption of specialized culture media, enzymes, and cellular analysis reagents in global research laboratories.

Clinical chemistry reagents: Clinical chemistry reagents play a vital role in hospital diagnostics and routine laboratory testing procedures worldwide. Approximately 61% of diagnostic laboratories increased utilization of automated clinical chemistry analyzers for metabolic disorder detection and organ function assessment. Demand for blood glucose testing reagents expanded by nearly 44% due to increasing diabetes prevalence globally. Hospitals reported around 41% growth in electrolyte testing and biochemical assay procedures utilizing advanced chemistry reagents. Automation adoption in diagnostic laboratories improved sample processing efficiency by approximately 36%, supporting higher reagent consumption volumes. Preventive healthcare programs and regular health screening initiatives contributed to nearly 38% expansion in routine diagnostic testing activities. Emerging economies also increased healthcare infrastructure investments, resulting in approximately 33% growth in laboratory modernization projects requiring high-performance chemistry reagents. Clinical chemistry reagents continue to support cardiovascular, liver, kidney, and endocrine disorder testing, while laboratory digitization and integrated analyzer systems further enhance diagnostic productivity and testing accuracy across healthcare facilities.

Immunoassay reagents: Immunoassay reagents are experiencing significant growth due to increasing infectious disease testing, cancer screening programs, and biomarker analysis applications. Approximately 57% of hospitals expanded immunoassay testing procedures for chronic disease diagnosis and therapeutic monitoring. Enzyme-linked immunosorbent assay technologies witnessed nearly 49% adoption growth in research laboratories and diagnostic centers. Biomarker-based oncology testing increased by around 43%, driving higher consumption of antibody reagents and immunological assay kits. Clinical laboratories reported approximately 37% expansion in autoimmune disorder testing utilizing advanced immunoassay platforms. Rapid diagnostic technologies integrating chemiluminescent immunoassays improved testing sensitivity by nearly 32%, encouraging wider adoption across healthcare facilities. Biotechnology firms also increased immunological research activities by approximately 35% for vaccine development and protein interaction studies. Multiplex immunoassay technologies gained popularity in precision medicine programs, enabling simultaneous biomarker analysis and improving diagnostic efficiency. Rising healthcare awareness and disease surveillance initiatives continue to support long-term demand for immunoassay reagent solutions globally.

Molecular diagnostic reagents: Molecular diagnostic reagents represent one of the fastest-expanding segments within the Life Science Reagents Market due to rising genomic analysis and infectious disease testing activities. Approximately 64% of advanced diagnostic laboratories adopted PCR-based reagent systems for pathogen detection and genetic mutation analysis. Next-generation sequencing workflows increased by nearly 51%, significantly boosting demand for nucleic acid extraction kits and amplification reagents. Cancer genomics studies expanded by around 47%, driving utilization of high-sensitivity molecular testing reagents. Precision medicine applications increased by approximately 44% across hospitals and biotechnology companies, supporting broader adoption of companion diagnostic assays. Automated molecular testing platforms improved diagnostic throughput by nearly 39%, enabling efficient reagent utilization in large-scale laboratory operations. Academic institutions also expanded genomic research programs by approximately 33%, contributing to higher procurement of sequencing enzymes and molecular assay consumables. Public health surveillance programs and pandemic preparedness initiatives further accelerated investment in molecular diagnostics infrastructure and laboratory testing technologies worldwide.

Other: Other life science reagents include chromatography reagents, electrophoresis chemicals, microbiology media, staining agents, and analytical laboratory consumables supporting diverse research and diagnostic applications. Approximately 48% of pharmaceutical laboratories increased chromatography reagent utilization for drug purity analysis and formulation testing. Protein electrophoresis procedures expanded by nearly 36% across biotechnology research facilities, increasing demand for gel reagents and buffer solutions. Microbiology testing laboratories reported approximately 41% growth in culture media consumption for bacterial identification and antimicrobial resistance analysis. Histopathology and tissue staining procedures increased by around 34% in diagnostic laboratories due to rising cancer biopsy testing volumes. Environmental and food safety testing activities also contributed to approximately 29% growth in specialty analytical reagent demand. Automation in laboratory workflows improved analytical testing efficiency by nearly 27%, encouraging higher adoption of standardized reagent kits and consumables. Expansion of industrial biotechnology and pharmaceutical quality control operations continues to strengthen demand for specialized laboratory reagents across multiple scientific disciplines.

BY APPLICATION

Scientific research: Scientific research applications account for a substantial portion of the Life Science Reagents Market due to increasing genomic studies, proteomics analysis, stem cell investigations, and biotechnology innovations across universities and research laboratories. Approximately 63% of academic laboratories increased molecular reagent utilization for DNA sequencing, biomarker analysis, and protein characterization studies. Cell-based experimentation activities expanded by nearly 48%, increasing demand for tissue culture reagents and assay kits in biomedical research facilities. More than 52% of government-funded research institutions integrated advanced molecular diagnostic platforms requiring high-purity reagents for experimental accuracy. Research related to gene editing technologies and CRISPR applications increased by around 44%, supporting reagent demand for nucleic acid amplification and cellular analysis. Automated laboratory platforms improved research efficiency by approximately 37%, encouraging higher reagent consumption for high-throughput screening activities. Immunological studies expanded by nearly 39% globally due to rising vaccine and infectious disease research programs. Biotechnology collaboration projects between universities and pharmaceutical firms increased by around 33%, further accelerating procurement of analytical and specialty laboratory reagents. Scientific research laboratories also reported approximately 29% growth in proteomics reagent consumption associated with biomarker discovery and precision medicine investigations. Advanced imaging techniques and bioinformatics-integrated testing procedures continue to strengthen demand for innovative life science reagents across scientific research environments.

Pharmaceuticals: Pharmaceutical applications represent a major segment within the Life Science Reagents Market due to increasing drug discovery, biologics development, and clinical trial activities worldwide. Approximately 59% of pharmaceutical companies expanded reagent procurement for high-throughput drug screening and molecular analysis workflows. Biologics and monoclonal antibody production activities increased by nearly 46%, significantly boosting demand for cell culture media, purification reagents, and protein analysis kits. Around 51% of pharmaceutical research centers adopted advanced molecular diagnostics to improve targeted therapy development and precision medicine initiatives. Toxicology testing and formulation analysis procedures expanded by approximately 42%, increasing utilization of chromatography and analytical chemistry reagents. Pharmaceutical manufacturers also reported nearly 38% growth in genomic testing applications for personalized medicine and companion diagnostics programs. Automated laboratory systems improved pharmaceutical testing efficiency by approximately 34%, enabling higher reagent throughput and reduced experimental variability. Clinical trial activities associated with oncology and rare disease therapies increased by nearly 31%, driving demand for immunoassay and biomarker analysis reagents. Furthermore, vaccine research and development programs accelerated by approximately 36%, creating sustained consumption of molecular biology and microbiology reagents across pharmaceutical manufacturing and research facilities globally.

Other: Other applications in the Life Science Reagents Market include clinical diagnostics, environmental testing, food safety analysis, forensic laboratories, and industrial biotechnology operations. Clinical diagnostic laboratories accounted for nearly 54% of specialty reagent consumption due to rising infectious disease testing and chronic disorder screening programs. Food safety testing activities increased by approximately 41%, driving demand for microbiological culture media, contamination detection reagents, and analytical assay kits. Environmental monitoring laboratories expanded testing volumes by nearly 36% for water quality analysis and industrial contamination studies. Forensic science laboratories reported approximately 33% growth in DNA analysis reagent utilization for criminal investigations and identity verification procedures. Industrial biotechnology applications involving enzyme production and microbial fermentation increased by around 29%, supporting consumption of specialty laboratory chemicals and purification reagents. Hospitals and pathology centers also expanded histopathology staining procedures by approximately 38%, increasing utilization of immunohistochemistry reagents and tissue analysis consumables. Rapid diagnostic testing adoption improved laboratory throughput efficiency by nearly 27%, supporting higher reagent demand across decentralized healthcare settings. Increasing laboratory automation, public health surveillance programs, and quality assurance initiatives continue to strengthen demand for specialized life science reagents across diverse application industries worldwide.

Life Science Reagents Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America maintains a leading position in the Life Science Reagents Market due to strong biotechnology infrastructure, advanced pharmaceutical manufacturing capabilities, and extensive genomic research activities. Approximately 68% of research laboratories across the region utilize molecular diagnostic reagents for genomic sequencing and infectious disease testing applications. More than 57% of hospitals adopted advanced immunoassay systems for cancer biomarker detection and chronic disease monitoring. Biotechnology companies increased reagent procurement by nearly 49% to support biologics development and regenerative medicine projects. Automated laboratory systems expanded by around 43%, improving testing efficiency and increasing demand for automation-compatible reagent kits. Clinical trial activities associated with precision medicine and targeted therapies increased by approximately 39%, further supporting molecular biology reagent utilization. Academic research institutions also reported nearly 35% growth in stem cell and proteomics research programs. Public health initiatives and advanced healthcare infrastructure continue to support high laboratory testing volumes, while pharmaceutical innovation and AI-integrated diagnostic platforms further strengthen Life Science Reagents Market Growth across North America.

Europe

Europe represents a significant region within the Life Science Reagents Market due to increasing investments in biomedical research, clinical diagnostics, and pharmaceutical innovation. Approximately 61% of European healthcare laboratories adopted advanced molecular testing technologies for oncology and infectious disease analysis. Research institutes across the region expanded genomic sequencing activities by nearly 47%, increasing demand for nucleic acid extraction and amplification reagents. Immunology research programs increased by approximately 42%, driving strong utilization of immunoassay kits and antibody reagents. Around 38% of pharmaceutical manufacturers integrated automated reagent handling systems to improve laboratory productivity and quality control operations. Environmental and food safety testing applications also contributed to approximately 31% growth in analytical chemistry reagent consumption. Regenerative medicine initiatives expanded by nearly 34%, increasing procurement of cell culture and tissue engineering reagents. Collaborative research projects between academic institutions and biotechnology firms strengthened innovation in precision diagnostics and personalized medicine. Europe also reported rising adoption of sustainable laboratory practices, with approximately 28% of manufacturers focusing on eco-friendly reagent packaging and reduced laboratory waste management solutions.

Asia-Pacific

Asia-Pacific is experiencing rapid expansion in the Life Science Reagents Market due to increasing healthcare investments, growing biotechnology industries, and rising clinical diagnostic activities. Approximately 66% of emerging biotechnology laboratories across the region expanded molecular biology testing operations, significantly increasing demand for PCR reagents and genomic sequencing kits. Government-supported healthcare modernization initiatives increased laboratory automation adoption by nearly 48%, improving reagent consumption efficiency across hospitals and diagnostic centers. Pharmaceutical manufacturing activities expanded by approximately 44%, boosting demand for analytical chemistry reagents and biologics development consumables. Academic research institutions reported around 41% growth in stem cell and regenerative medicine projects utilizing advanced cell culture reagents. Infectious disease surveillance programs increased molecular diagnostic testing volumes by nearly 53%, strengthening demand for high-sensitivity assay reagents. Clinical laboratories also experienced approximately 36% growth in chronic disease screening applications requiring immunoassay and biochemical testing reagents. Expanding healthcare access, rising medical tourism, and increased biotechnology collaborations continue to create substantial Life Science Reagents Market Opportunities across Asia-Pacific, particularly within precision medicine and laboratory automation sectors.

Middle East & Africa

The Middle East & Africa region is gradually strengthening its position in the Life Science Reagents Market due to expanding healthcare infrastructure, rising laboratory modernization projects, and increasing infectious disease testing activities. Approximately 52% of diagnostic laboratories in the region expanded molecular testing capabilities for viral and bacterial disease analysis. Government-supported healthcare reforms increased investment in laboratory automation by nearly 39%, supporting higher reagent utilization across hospitals and clinical centers. Pharmaceutical and biotechnology research activities expanded by approximately 33%, increasing demand for analytical chemistry and molecular diagnostic reagents. Public health surveillance programs improved infectious disease monitoring efficiency by around 41%, encouraging broader adoption of PCR-based diagnostic technologies. Academic research institutions also increased biomedical research initiatives by nearly 28%, driving demand for cell culture and immunological assay reagents. Food safety and environmental testing laboratories reported approximately 31% growth in specialty analytical reagent utilization. In addition, international healthcare collaborations and expanding diagnostic laboratory networks contributed to stronger procurement of advanced laboratory consumables. The region continues to witness increasing adoption of precision diagnostics and automated laboratory systems, supporting future growth in life science reagent applications.

List of Key Life Science Reagents Market Companies

• Danaher
• Roche
• Thermo Fisher Scientific
• Merck Millipore
• Abbott
• BioMerieux
• BD
• Siemens Healthcare
• Sysmex
• Bio-Rad Laboratories
• Lonza Group
• Agilent Technologies
• PerkinElmer
• Meridian Life Science
• Promega

Life Science Reagents Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 58196.8 Million in 2026
Market Size Value By	USD 157151.19 Million by 2035
Growth Rate	CAGR of 11.67% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered
	By Type Cell and tissue culture reagents Clinical chemistry reagents Immunoassay reagents Molecular diagnostic reagents Other
	By Application Scientific research Pharmaceuticals Other